RMC5127
Product Specifications
CAS Number
3056146-38-1
Target
Apoptosis|||Kras|||Ras|||Kras
Related Pathways
GPCR/G Protein|||MAPK|||Apoptosis
Purity
0.9754
Bioactivity
RMC5127 is an orally available, mutation-selective RAS G12V inhibitor exhibiting central nervous system (CNS) and brain permeability. It suppresses the RAS pathway and induces apoptosis in KRAS G12V mutant cancer cells, demonstrating antitumour activity.
Smiles
C[C@H](OC)C(N=C1)=[C@@]([C@@]2=C(CC(C)(C)COC([C@H]3NN(C([C@@H](NC([C@H]4OC[C@@H]4C)=O)[C@H]5N6CC7(COC7)C6)=O)C8CC3C8)=O)C9=C(C=CC(C%10=CSC5=N%10)=C9)N2CCOC%11CCOCC%11)C=C1N%12CCN(C%13CC%13)CC%12
Molecular Formula
C57H75N9O9S
Molecular Weight
1062.32
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15254560 1 Vial
Lentiviral mouse Ackr3 shRNA (UAS) - Lentiviral mouse Ackr3 shRNA (UAS, iRFP) plasmid
Ask
View Details 
133540-Biotin 100 µL
SMAD4 (Mothers Against Decapentaplegic Homolog 4, SMAD 4, Mothers Against DPP Homolog 4, Deletion Target In Pancreatic Carcinoma 4, MAD Homolog 4, SMAD Family Member 4, hSMAD4, DPC4, MADH4) (Biotin)
Ask
View Details 